Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
NEGENT
Neopharmed Gentili SpA€890
1EMEA
Jun 18, 2026
currency
EUR
size (m)
890.000
maturity
Jun 29, 2033
type
Floating
tenor
7.000
call
1
registration
144A/Reg S
benchmark
3mEu
ranking
Sr. Secured
moody's
B3
s&p
B
fitch
B
size description
-
re-open/tap
No
ipt
High 3s
ipt-pxd
-50
guidance
3mEu+325-350
spread
325
coupon
3mEu+325
spread set
-
price
100.00000
yield
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
joint leads
AKR, CAG, GSC, INS, ...
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
active leads
joint leads
AKR, CAG, GSC, INS, ...
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
First Pay: 2026-10-15; Redemption: 2033-05-29; Registration: 144A/Reg S; Comments: MWC: B+50;
Deal Comments
The deal was upsized from EUR425m to EUR890m
Use of Proceeds
Refinance existing indebtedness, fund a distribution to parent to repay a portion of the PIK Notes, and pay related fees and expenses
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.